Cirrhosis cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Cirrhosis}} {{CMG}} {{AOEIC}} {{UJ}} ==Overview== ==Reference== {{reflist|2}}" |
|||
| Line 3: | Line 3: | ||
{{CMG}} {{AOEIC}} {{UJ}} | {{CMG}} {{AOEIC}} {{UJ}} | ||
==Overview== | ==Overview== | ||
According to a report from The National Center for Health Statistics, Cirrhosis and chronic liver disease accounted for more than 25,000 deaths and 373,000 hospital discharges in the United States in 1998. | |||
==Reference== | ==Reference== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 15:37, 6 September 2012
|
Cirrhosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case studies |
|
Cirrhosis cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Cirrhosis cost-effectiveness of therapy |
|
Risk calculators and risk factors for Cirrhosis cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-In-Chief: Ujjwal Rastogi, M.B.B.S. [2]
Overview
According to a report from The National Center for Health Statistics, Cirrhosis and chronic liver disease accounted for more than 25,000 deaths and 373,000 hospital discharges in the United States in 1998.